Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Catalyst Pharmaceuticals (CPRX) Deferred Taxes (2020 - 2026)

Catalyst Pharmaceuticals filings provide 7 years of Deferred Taxes readings, the most recent being $2.3 million for Q1 2026.

  • On a quarterly basis, Deferred Taxes rose 0.65% to $2.3 million in Q1 2026 year-over-year; TTM through Mar 2026 was $6.9 million, a 31.11% decrease, with the full-year FY2025 number at $6.8 million, down 27.05% from a year prior.
  • Deferred Taxes hit $2.3 million in Q1 2026 for Catalyst Pharmaceuticals, down from $4.5 million in the prior quarter.
  • In the past five years, Deferred Taxes ranged from a high of $13.9 million in Q3 2023 to a low of -$2.6 million in Q4 2024.
  • Median Deferred Taxes over the past 5 years was $1.6 million (2024), compared with a mean of $1.9 million.
  • Biggest five-year swings in Deferred Taxes: surged 1592.83% in 2023 and later plummeted 189.35% in 2024.
  • Catalyst Pharmaceuticals' Deferred Taxes stood at -$1.3 million in 2022, then skyrocketed by 31.28% to -$883000.0 in 2023, then plummeted by 189.35% to -$2.6 million in 2024, then soared by 276.56% to $4.5 million in 2025, then crashed by 48.22% to $2.3 million in 2026.
  • The last three reported values for Deferred Taxes were $2.3 million (Q1 2026), $4.5 million (Q4 2025), and -$2.4 million (Q3 2025) per Business Quant data.